Table 2: Relationship between histopathologic evaluation and KRAS point mutation in specimens of pancreatic cancer (62 cases) obtained by EUS-FXA; citation from [7].

HistologyKRAS point mutation positive

Insufficient material73 (43%)
No malignancy117 (64%)
Atypical54 (80%)
Suspicion of malignancy1512 (80%)
Malignancy material2420 (83%)

Total6246